PetMed Express (PetMed Express) Interest Expense

: $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PetMed Express's interest expense for the three months ended in Dec. 2023 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PetMed Express's Operating Income for the three months ended in Dec. 2023 was $ -3.1 Mil. PetMed Express's Interest Expense for the three months ended in Dec. 2023 was $ 0.0 Mil. GuruFocus does not calculate PetMed Express's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PetMed Express Interest Expense Historical Data

The historical data trend for PetMed Express's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetMed Express Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

PetMed Express Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense																-	-	-	-	-

PetMed Express Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

PetMed Express (NAS:PETS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PetMed Express's Interest Expense for the three months ended in Dec. 2023 was $0.0 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-3.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $0.9 Mil.

PetMed Express's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

GuruFocus does not calculate PetMed Express's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. PetMed Express Inc has enough cash to cover all of its debt. Its financial situation is stable.

PetMed Express (PetMed Express) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PetMed Express Inc (NAS:PETS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PQM:Germany PQM:Germany

Address

420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445

Website

https://www.petmeds.com

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

Executives

Gian Fulgoni	director
Christine Chambers	officer: CFO	1501 1ST AVENUE SOUTH, STE. 600, SEATTLE WA 98134
Mathew N Hulett	director, officer: CEO & President	1621 NORTH KENT STREET, SUITE 1200, ARLINGTON VA 22209
Campbell Leslie C.g.	director	C/O COUPA SOFTWARE INC., 1855 S. GRANT STREET, SAN MATEO CA 94402
Diana G Purcel	director	C/O FAMOUS DVES OF AMERICA INC, 8091 WALLACE ROAD, EDEN PRAIRIE MN 55344
Moseley Mark Bradley Jr	other: Chief Technology Info Officer	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Daniel Job Pingree	other: Chief Marketing Officer	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Sandra Yvette Campos	director	4900 E DUBLIN GRANVILLE RD, COLUMBUS OH 43081
Jacqueline Paula Smith	other: Vice President of People	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Carolyn Carden	other: VP of Product	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Peter Cobb	director	DSW, INC., 810 DSW DRIVE, COLUMBUS OH 43219
Jodi Watson	director	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Frank J Formica	director	1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069
Bruce S Rosenbloom	officer: Chief Financial Officer	6401 CONGRESS AVENUE, SUITE 250, BOCA RATON FL 33487
Menderes Akdag	director, officer: Chief Executive Officer	1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069